シンポジウム13（II-S13）
小児循環器領域の遺伝子医学の革新

[II-S13-01] Genetic Advances in Congenital Heart Disease

^○Vidu Garg (Director of the Center for Cardiovascular Research at Nationwide Children's hospital (OH, USA))

Cardiovascular malformations are the most common type of birth defect and result in significant mortality worldwide. The etiology for the majority of these anomalies remains unknown but genetic contributors are recognized as playing an important role. Genomic medicine has rapidly advanced over the past decade, and in some fields allows clinicians the ability to identify genetic contributors for a disease which lead to both tailored personalized treatment regimens and appropriate genetic counseling. This trend is becoming more appreciated in the field of congenital heart disease. An increasing number of genetic etiologies of human congenital heart defects can be defined due to the convergence of an increased molecular understanding of heart development and advances in genetic technologies.